Updated Jul 16, 2026
CARROLL J MARTIN has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | ESPR | Esperion Therapeutics, Inc. | D — Derivative transaction | 177.5K | — | |
| 2026-06-01 | ESPR | Esperion Therapeutics, Inc. | A — Grant or award | 79.9K | $0.00 | |
| 2025-05-29 | ESPR | Esperion Therapeutics, Inc. | A — Grant or award | 33.0K | $0.00 | |
| 2024-12-18 | CTLT | Catalent, Inc. | D — Derivative transaction | 32.7K | — | |
| 2024-11-01 | CTLT | Catalent, Inc. | A — Grant or award | 4.7K | $0.00 |
CARROLL J MARTIN is a corporate insider — currently tracked as Director of Esperion Therapeutics, Inc. (ESPR). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CARROLL J MARTIN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.